Factors influencing willingness to participate in ophthalmic clinical trials and strategies for effective recruitment.

AIM: To explore the factors influencing individuals' willingness to participate in ophthalmic clinical trials. METHODS: A questionnaire survey was conducted from January to April 2021 among patients and their family members at Zhongshan Ophthalmic Center, Sun Yat-sen University, in Guangzhou, China. The survey gathered data on respondents' willingness, demographic and socioeconomic profiles, as well as their reasons and concerns regarding engagement in clinical trials. RESULTS: Of the 1078 residents surveyed (mean age 31.2±13.1y; 65.8% females) in Guangzhou, 749 (69.5%) expressed a willingness to participate in future ophthalmic clinical trials. Specific characteristics associated with greater willingness included a younger age, lower annual income, higher education, prior participation experience, previous ophthalmic treatment, and a better understanding of clinical trials. With the exception of age, these characteristics were significantly linked to a higher willingness. The primary barrier to participation, expressed by 64.8% of those willing and 54.4% of those unwilling, was "Uncertain efficacy". In terms of motivations, the willing group ranked "Better therapeutic benefits" (35.0%), "Professional monitoring" (34.3%), and "Trust in healthcare professionals" (33.1%) as their top three reasons, whereas the unwilling participants indicated "Full comprehension of the protocol" (46.2%) as the key facilitator. CONCLUSION: This study reveals a substantial willingness to participate in ophthalmic clinical trials and demonstrates the predictive role of demographic and socioeconomic factors. Variations in motivators and concerns between willing and unwilling participants highlight the significance of tailored recruitment strategies. Importantly, the need for and trust in healthcare professionals stand out as powerful motivations, underscoring the importance of enhancing physician-patient relationships, adopting patient-centered communication approaches, and addressing individualized needs to improve accrual rates.

Precise Control of Selenium Functionalization in Non-Fullerene Acceptors Enabling High-Efficiency Organic Solar Cells.

Central π-core engineering of non-fullerene small molecule acceptors (NF-SMAs) is effective in boosting the performance of organic solar cells (OSCs). Especially, selenium (Se) functionalization of NF-SMAs is considered a promising strategy but the structure-performance relationship remains unclear. Here, we synthesize two isomeric alkylphenyl-substituted selenopheno[3,2-b]thiophene-based NF-SMAs named mPh4F-TS and mPh4F-ST with different substitution positions, and contrast them with the thieno[3,2-b]thiophene-based analogue, mPh4F-TT. When placing Se atoms at the outer positions of the π-core, mPh4F-TS shows the most red-shifted absorption and compact molecular stacking. The PM6 : mPh4F-TS devices exhibit excellent absorption, high charge carrier mobility, and reduced energy loss. Consequently, PM6 : mPh4F-TS achieves more balanced photovoltaic parameters and yields an efficiency of 18.05 %, which highlights that precisely manipulating selenium functionalization is a practicable way toward high-efficiency OSCs.

Natural history of glaucomatous optic neuropathy in highly myopic Chinese: study protocol for a registry cohort study.

INTRODUCTION: Myopic maculopathy and glaucoma belong to the most common causes of irreversible blindness worldwide and, having an ocular axial elongation as one of their main risk factors, can occur together. The detection of glaucomatous optic neuropathy (GON) in highly myopic eyes is clinically and technically difficult, and there is no information available, neither about the natural course of GON or about the course of GON under intraocular pressure-lowering therapy. We therefore designed this study to explore the natural course of GON in highly myopic eyes. METHODS AND ANALYSIS: In this single-centred longitudinal registry cohort study, 813 highly myopic individuals will be recruited and undergo detailed ophthalmic examinations. High myopia is defined by a myopic refractive error of ≥-6 D or an axial length of ≥26.5 mm. GON is defined by a glaucomatous appearance of the optic nerve head or glaucomatous visual field (VF) defects. GON progression is defined by either change of the optic disc or VF. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the ethical committee of the Zhongshan Ophthalmic Center (ZOC), Sun Yat-sen University, China (ID: 2019KYPJ079). All the participants are required to provide informed consents. Results will be disseminated through scientific meetings and published in peer-reviewed journals. The data will be deposited at the clinical research centre in ZOC using electronic data capture system, and a copy of paper files will also be kept. Only members of the project team will have access to these data. TRIAL REGISTRATION NUMBER: NCT04302220.

Random Polymerization Strategy Leads to a Family of Donor Polymers Enabling Well-Controlled Morphology and Multiple Cases of High-Performance Organic Solar Cells.

Developing high-performance donor polymers is important for nonfullerene organic solar cells (NF-OSCs), as state-of-the-art nonfullerene acceptors can only perform well if they are coupled with a matching donor with suitable energy levels. However, there are very limited choices of donor polymers for NF-OSCs, and the most commonly used ones are polymers named PM6 and PM7, which suffer from several problems. First, the performance of these polymers (particularly PM7) relies on precise control of their molecular weights. Also, their optimal morphology is extremely sensitive to any structural modification. In this work, a family of donor polymers is developed based on a random polymerization strategy. These polymers can achieve well-controlled morphology and high-performance with a variety of chemical structures and molecular weights. The polymer donors are D-A1-D-A2-type random copolymers in which the D and A1 units are monomers originating from PM6 or PM7, while the A2 unit comprises an electron-deficient core flanked by two thiophene rings with branched alkyl chains. Consequently, multiple cases of highly efficient NF-OSCs are achieved with efficiencies between 16.0% and 17.1%. As the electron-deficient cores can be changed to many other structural units, the strategy can easily expand the choices of high-performance donor polymers for NF-OSCs.

Hepatic Polarization Accelerated by Mechanical Compaction Involves HNF4α Activation.

There remain few data about the role of homeostatic compaction in hepatic polarization. A previous study has found that mechanical compaction can accelerate hepatocyte polarization; however, the cellular mechanism underlying the effect is mostly unclear. Hepatocyte nuclear factor 4 alpha (HNF4α) is crucial for hepatic polarization in liver morphogenesis. Therefore, we sought to identify any possible involvement of HNF4α in the process of hepatocyte polarization accelerated by mechanical compaction. We first verified in the nonhepatic cell model HEK-293T, and the hepatic cell model primary hepatocytes that the mechanical compaction on cell aggregates simulated by using transient centrifugation can directly activate the expression of HNF4α promoters. Moreover, data using primary hepatocytes showed that the HNF4α expression is positively associated with the levels of compaction force: 2.1-folds higher at the mRNA level and 2.1-folds higher at the protein level for 500 g vs. 0 g. Furthermore, activated HNF4α expression is associated with the enhanced biliary canalicular formation and the increased production of albumin and urea. Pretreatment with Latrunculin B, an inhibitor of F-actin, and SHE78-7, an inhibitor of E-cadherin, which both interrupt the pathway of mechanical transduction, partially but significantly reduced the HNF4α expression and production of albumin and urea. In conclusion, HNF4α can be actively involved in the hepatic polarization in the context of environmental mechanical compaction.